Feb 19, 2025
918:913
For every 913 shares held, investors received 918. The price per share adjusted from $1.28 to $1.28.
The split itself did not change the total investment value.
PYC Therapeutics Limited (ASX:PYC) operates in the Pharmaceuticals: major industry.
PYC Therapeutics Limited company overviewPYC Therapeutics Limited's most recent stock split was on February 19, 2025. It was a 918-for-913 forward split, so shareholders received 918 shares for every 913 they held.
PYC Therapeutics Limited (ASX:PYC) has split its stock 8 times: a 81-for-80 split on September 2, 2010, a 85-for-81 split on December 5, 2013, a 6-for-5 split on July 7, 2015, a 1019-for-1000 split on November 4, 2019, a 407-for-404 split on October 22, 2020, a 85-for-84 split on March 18, 2024, a 1-for-10 reverse split on November 26, 2024, and a 918-for-913 split on February 19, 2025.
PYC Therapeutics Limited has split its stock 8 times. This history records 8 splits between September 2, 2010 and February 19, 2025.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In PYC Therapeutics Limited's 918-for-913 split on February 19, 2025, every 913 shares became 918 shares.
PYC Therapeutics Limited has not announced a new split in our records. Its most recent split was on February 19, 2025, 1 year ago. Companies announce splits in advance, and any new ASX:PYC split will appear on this page.
Already premium?